We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$105M
AUM Growth
+$31M
Cap. Flow
+$10.2M
Cap. Flow %
9.65%
Top 10 Hldgs %
37.42%
Holding
105
New
22
Increased
35
Reduced
19
Closed
22
Avg Time Held Equity + Options
2.9 quarters
Top 10 Avg Time Held Equity + Options
0.5 quarters
Top 20 Avg Time Held Equity + Options
0.7 quarters
Avg Time Held Equity only
3.3 quarters
Top 10 Avg Time Held Equity only
0.4 quarters
Top 20 Avg Time Held Equity only
0.7 quarters

Top Buys

Rank Stock Value
1
SNNA
Sienna Biopharmaceuticals, Inc.
SNNA
+$6.61M
2
AGN.PRA
Allergan plc
AGN.PRA
+$1.98M
3
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$1.72M
4
CNC icon
Centene
CNC
+$1.44M
5
JD icon
JD.com
JD
+$1.26M

Top Sells

Rank Stock Value
1
KITE
Kite Pharma, Inc.
KITE
+$4.01M
2
UHS icon
Universal Health Services
UHS
+$1.84M
3
PCRX icon
Pacira BioSciences
PCRX
+$1.72M
4
MCK icon
McKesson
MCK
+$1.63M
5
BABA icon
Alibaba
BABA
+$1.15M

Sector Composition

Rank Sector Weight
1 Healthcare 43.3%
2 Miscellaneous 26.21%
3 Technology 14.09%
4 Communication Services 7.52%
5 Consumer Discretionary 5.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
QQQ icon
1
PUT
Invesco QQQ Trust
QQQ
$491B
$8.23M 7.81%
56,600
+43,300
+326% +$6.2M
2017 Q2
1 quarter
SNNA
2
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$6.7M 6.35%
+300,940
New +$6.61M
2017 Q3
0 quarters
PTLA
3
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$4.41M 4.18%
81,569
+29,300
+56% +$1.72M
2016 Q4
3 quarters
PFE icon
4
CALL
Pfizer
PFE
$166B
$4.08M 3.87%
+120,367
New +$3.87M
2017 Q3
0 quarters
XBI icon
5
CALL
State Street SPDR S&P Biotech ETF
XBI
$9.75B
$3.4M 3.23%
+39,300
New +$3.15M
2017 Q3
0 quarters
ELV icon
6
Elevance Health
ELV
$91.9B
$2.66M 2.52%
14,004
+1,470
+12% +$280K
2016 Q4
3 quarters
PBYI icon
7
Puma Biotechnology
PBYI
$528M
$2.55M 2.42%
21,294
-7,988
-27% -$743K
2016 Q4
3 quarters
GDDY icon
8
GoDaddy
GDDY
$13B
$2.53M 2.4%
58,091
+11,525
+25% +$497K
2016 Q4
3 quarters
EW icon
9
Edwards Lifesciences
EW
$49.2B
$2.52M 2.39%
69,267
+27,453
+66% +$1.05M
2014 Q4
11 quarters
META icon
10
Meta Platforms (Facebook)
META
$1.89T
$2.37M 2.25%
13,853
+6,902
+99% +$1.15M
2013 Q4
15 quarters
BAX icon
11
Baxter International
BAX
$12.8B
$2.28M 2.17%
36,383
+9,628
+36% +$595K
2017 Q1
2 quarters
ABT icon
12
Abbott
ABT
$177B
$2.13M 2.02%
39,888
+14,993
+60% +$752K
2017 Q2
1 quarter
AMZN icon
13
Amazon
AMZN
$2.76T
$2.12M 2.01%
44,100
+17,400
+65% +$855K
2017 Q2
1 quarter
CRM icon
14
Salesforce
CRM
$193B
$2.08M 1.97%
22,275
+12,356
+125% +$1.14M
2017 Q2
1 quarter
GOOGL icon
15
Alphabet (Google) Class A
GOOGL
$4.33T
$1.97M 1.87%
40,400
+22,100
+121% +$1.05M
2017 Q2
1 quarter
GDX icon
16
PUT
VanEck Gold Miners ETF
GDX
$25B
$1.93M 1.83%
+20,700
New +$478K
2017 Q3
0 quarters
JD icon
17
JD.com
JD
$35.9B
$1.84M 1.74%
48,124
+29,505
+158% +$1.26M
2017 Q2
1 quarter
MSFT icon
18
Microsoft
MSFT
$4T
$1.81M 1.72%
24,356
-1,628
-6% -$119K
2017 Q1
2 quarters
CI icon
19
Cigna
CI
$75.4B
$1.77M 1.68%
9,466
+1,244
+15% +$221K
2016 Q3
4 quarters
AGN.PRA
20
DELISTED
Allergan plc
AGN.PRA
$1.76M 1.67%
+2,383
New +$1.98M
2017 Q3
0 quarters
ATVI
21
DELISTED
Activision Blizzard
ATVI
$1.67M 1.58%
25,856
+14,945
+137% +$932K
2017 Q2
1 quarter
ZAYO
22
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$1.64M 1.55%
47,545
+23,357
+97% +$775K
2016 Q3
4 quarters
CNC icon
23
Centene
CNC
$34.1B
$1.61M 1.53%
+33,336
New +$1.44M
2017 Q3
0 quarters
AERI
24
DELISTED
Aerie Pharmaceuticals
AERI
$1.54M 1.46%
31,702
-794
-2% -$43.3K
2015 Q1
10 quarters
BPMC icon
25
DELISTED
Blueprint Medicines
BPMC
$1.48M 1.41%
21,252
+2,630
+14% +$141K
2015 Q2
9 quarters
1
2 3 4

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q3 2017 Portfolio in Review

As of Q3 2017, Partner Investment Management held 105 positions worth $105M, up 42% from $74.4M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Partner Investment Management deployed $10.2M of net new capital in Q3 2017, opening 22 new positions and adding to 35 existing holdings. Its largest new stake was Sienna Biopharmaceuticals, Inc.: 300,940 shares worth $6.7M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 53% a quarter earlier, followed by Miscellaneous and Technology.

On the sell side, the largest reduction was Kite Pharma, Inc., an estimated $4.01M trimmed.

  • Partner Investment Management's largest Q3 2017 buy was Sienna Biopharmaceuticals, Inc.: 300,940 shares worth $6.7M.
  • Partner Investment Management added most to Portola Pharmaceuticals, Inc. in Q3 2017, an estimated $1.72M increase.
  • Partner Investment Management's biggest Q3 2017 reduction was Kite Pharma, Inc., cutting an estimated $4.01M.
  • Partner Investment Management fully exited Universal Health Services in Q3 2017, selling an estimated $1.84M.
  • Partner Investment Management's ten largest holdings make up 37% of its $105M portfolio in Q3 2017.
  • Partner Investment Management opened 22 new positions and closed 22 in Q3 2017.
  • Partner Investment Management's portfolio value rose 42% quarter-over-quarter to $105M.

Based on Partner Investment Management's 13F filing for Q3 2017, filed 14 Nov 2017.